Claims
- 1. A method of detecting an ovarian tumor in an individual, comprising the step of:measuring a level of antileukoprotease in a sample from said individual, wherein if said level of antileukoprotease exceeds a mean basal level of antileukoprotease in nondiseased individuals by 2 standard deviations or greater, said individual has said ovarian tumor.
- 2. The method of claim 1, wherein said tumor is selected from the group consisting of a low malignant potential tumor and an ovarian carcinoma.
- 3. The method of claim 2, wherein said ovarian carcinoma is selected from the group consisting of a serous carcinoma, a mucinous carcinoma, an endometrioid carcinoma and a clear cell carcinoma.
- 4. The method of claim 1, wherein said antileukoprotease is detected in a sample selected from the group consisting of an ovarian secretion, an ovarian biopsy, a metastatic tumor biopsy and blood.
- 5. The method of claim 1, wherein said antileukoprotease is detected by a method selected from the group consisting of western blot analysis, immunohistochemical staining, and immunochemical methods.
Parent Case Info
CROSS-REFERENCE TO RELATED APPLICATION
This non-provisional patent application claims benefit of provisional patent application U.S. Ser. No. 60/159,972, filed Oct. 18, 1999, now abandoned.
Non-Patent Literature Citations (2)
Entry |
Koshikawa et al (1996, Journal of Biochemistry 119: 334-339).* |
MacDonald et al (1998, Annals Academy of Medicine Singapore 27: 676-82, Abstract only). |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/159972 |
Oct 1999 |
US |